Upload

Loading...

This video is unavailable.

HIV/AIDS vaccine developed at Western proceeding to human clinical trials

Like this video?

Sign in to make your opinion count.

Don't like this video?

Sign in to make your opinion count.

Want to watch this again later?

Sign in to add this video to a playlist.

Uploaded on Dec 16, 2011

London, Ontario CANADA --The first and only preventative HIV vaccine based on a genetically modified killed whole virus has received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.

Developed by Dr. Chil-Yong Kang and his team at The University of Western Ontario, with the support of Sumagen Canada, the vaccine (SAV001) holds tremendous promise, having already proven to stimulate strong immune responses in preliminary toxicology tests with no adverse effects or safety risks. It is the only HIV vaccine currently under development in Canada, and one of only a few in the world.

  • Category

  • License

    • Standard YouTube License

Loading...

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading...

Loading...
Working...
to add this to Watch Later

Add to